摘要
腹膜透析(PD)是终末期糖尿病肾病(ESDN)患者肾脏替代治疗方式之一。但由于使用含糖透析液,透析过程中蛋白丢失、容量超负荷等问题,导致糖尿病肾病PD患者较非糖尿病肾病PD患者更易出现血糖控制不佳、脂代谢紊乱、心血管事件、营养不良、感染和微炎症等并发症。因此在ESDN患者中使用PD并不优于血液透析。
Peritoneal dialysis （PD） is a form of renal replacement therapy to end-stage diabetic nephropathy （ESDN）. Since protein loss through dialysis and volume overload are more severe in patients with diabetic nephropathy than in patients with non-diabetic nephropathy and the application of glucose-containing solution, diabetic PD patients are more common to suffer from complications including glucose and lipid metabolic disorder, cardiovascular events, malnutrition, infection and micro-inflammation. Therefore, the application of peritoneal dialysis is not superior to hemodialysis in ESDN patients.
出处
《肾脏病与透析肾移植杂志》
CAS
CSCD
北大核心
2013年第5期485-489,共5页
Chinese Journal of Nephrology,Dialysis & Transplantation
关键词
腹膜透析
终末期糖尿病肾病
难题
peritoneal dialysis
end stage diabetic nephropathy
difficult problems
